The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia

Andrew J. Flores, Mitchell J. Bartlett, Brandon K. Root, Kate L. Parent, Michael L. Heien, Frank Porreca, Robin Polt, Scott J. Sherman, Torsten Falk

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'The combination of the opioid glycopeptide MMP-2200 and a NMDA receptor antagonist reduced L-DOPA-induced dyskinesia and MMP-2200 by itself reduced dopamine receptor 2-like agonist-induced dyskinesia'. Together they form a unique fingerprint.

Medicine & Life Sciences